International Assets Investment Management LLC purchased a new position in Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 102,675 shares of the company's stock, valued at approximately $1,899,000. International Assets Investment Management LLC owned approximately 0.28% of Crescent Capital BDC as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Sun Life Financial Inc. boosted its position in shares of Crescent Capital BDC by 8.1% during the second quarter. Sun Life Financial Inc. now owns 1,843,766 shares of the company's stock worth $34,626,000 after acquiring an additional 137,684 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of Crescent Capital BDC by 31.9% during the 2nd quarter. Millennium Management LLC now owns 268,097 shares of the company's stock valued at $5,035,000 after purchasing an additional 64,902 shares during the last quarter. Deerfield Management Company L.P. Series C bought a new position in shares of Crescent Capital BDC during the 2nd quarter valued at about $1,021,000. Marshall Wace LLP purchased a new position in shares of Crescent Capital BDC during the second quarter valued at about $767,000. Finally, Hennion & Walsh Asset Management Inc. increased its holdings in shares of Crescent Capital BDC by 182.3% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 49,482 shares of the company's stock worth $929,000 after purchasing an additional 31,952 shares during the last quarter. 49.46% of the stock is owned by institutional investors.
Crescent Capital BDC Trading Down 2.6 %
CCAP traded down $0.47 during trading on Monday, reaching $17.55. The company had a trading volume of 211,793 shares, compared to its average volume of 132,189. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. Crescent Capital BDC, Inc. has a 52 week low of $15.91 and a 52 week high of $19.63. The stock has a market cap of $650.40 million, a P/E ratio of 6.38 and a beta of 0.81. The business has a 50 day simple moving average of $18.41 and a 200-day simple moving average of $18.36.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.58 by $0.01. The company had revenue of $48.95 million for the quarter, compared to the consensus estimate of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same period in the prior year, the firm posted $0.56 EPS. On average, equities analysts anticipate that Crescent Capital BDC, Inc. will post 2.35 EPS for the current fiscal year.
Crescent Capital BDC Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 9.57%. This is an increase from Crescent Capital BDC's previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Monday, September 30th. Crescent Capital BDC's dividend payout ratio is presently 61.09%.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on CCAP shares. LADENBURG THALM/SH SH assumed coverage on Crescent Capital BDC in a research note on Monday, September 30th. They set a "buy" rating and a $20.00 price target for the company. Wells Fargo & Company lowered their target price on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 14th. Finally, Bank of America reduced their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating on the stock in a research report on Thursday, August 15th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.00.
Read Our Latest Stock Report on Crescent Capital BDC
Crescent Capital BDC Company Profile
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Articles
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
